Literature DB >> 30190896

Current clinical trials for melanoma vaccines: where do we stand?

Adam I Riker1, Erika Bisgaard1.   

Abstract

Entities:  

Keywords:  T cells; cancer vaccines; checkpoint inhibitors; immune system; immunotherapy; intralesional therapy; melanoma; metastatic melanoma; targeted therapy; viral oncolytic therapy

Year:  2016        PMID： 30190896      PMCID： PMC6094694          DOI： 10.2217/mmt-2016-0009

Source DB:  PubMed          Journal:  Melanoma Manag        ISSN： 2045-0885


× No keyword cloud information.
  11 in total

1.  gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma.

Authors:  Douglas J Schwartzentruber; David H Lawson; Jon M Richards; Robert M Conry; Donald M Miller; Jonathan Treisman; Fawaz Gailani; Lee Riley; Kevin Conlon; Barbara Pockaj; Kari L Kendra; Richard L White; Rene Gonzalez; Timothy M Kuzel; Brendan Curti; Phillip D Leming; Eric D Whitman; Jai Balkissoon; Douglas S Reintgen; Howard Kaufman; Francesco M Marincola; Maria J Merino; Steven A Rosenberg; Peter Choyke; Don Vena; Patrick Hwu
Journal:  N Engl J Med       Date:  2011-06-02       Impact factor: 91.245

Review 2.  Melanoma vaccines.

Authors:  James C Yang
Journal:  Cancer J       Date:  2011 Sep-Oct       Impact factor: 3.360

3.  Cancer vaccines: pessimism in check.

Authors:  Simone Mocellin; Susanna Mandruzzato; Vincenzo Bronte; Francesco M Marincola
Journal:  Nat Med       Date:  2004-12       Impact factor: 53.440

4.  Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma.

Authors:  Robert H I Andtbacka; Howard L Kaufman; Frances Collichio; Thomas Amatruda; Neil Senzer; Jason Chesney; Keith A Delman; Lynn E Spitler; Igor Puzanov; Sanjiv S Agarwala; Mohammed Milhem; Lee Cranmer; Brendan Curti; Karl Lewis; Merrick Ross; Troy Guthrie; Gerald P Linette; Gregory A Daniels; Kevin Harrington; Mark R Middleton; Wilson H Miller; Jonathan S Zager; Yining Ye; Bin Yao; Ai Li; Susan Doleman; Ari VanderWalde; Jennifer Gansert; Robert S Coffin
Journal:  J Clin Oncol       Date:  2015-05-26       Impact factor: 44.544

5.  Effect of granulocyte/macrophage colony-stimulating factor on circulating CD8+ and CD4+ T-cell responses to a multipeptide melanoma vaccine: outcome of a multicenter randomized trial.

Authors:  Craig L Slingluff; Gina R Petroni; Walter C Olson; Mark E Smolkin; Merrick I Ross; Naomi B Haas; William W Grosh; Marc E Boisvert; John M Kirkwood; Kimberly A Chianese-Bullock
Journal:  Clin Cancer Res       Date:  2009-11-10       Impact factor: 12.531

6.  Dendritic cell vaccination combined with CTLA4 blockade in patients with metastatic melanoma.

Authors:  Antoni Ribas; Begoña Comin-Anduix; Bartosz Chmielowski; Jason Jalil; Pilar de la Rocha; Tara A McCannel; Maria Teresa Ochoa; Elizabeth Seja; Arturo Villanueva; Denise K Oseguera; Bradley R Straatsma; Alistair J Cochran; John A Glaspy; Liu Hui; Francesco M Marincola; Ena Wang; James S Economou; Jesus Gomez-Navarro
Journal:  Clin Cancer Res       Date:  2009-09-29       Impact factor: 12.531

7.  Cancer immunotherapy: moving beyond current vaccines.

Authors:  Steven A Rosenberg; James C Yang; Nicholas P Restifo
Journal:  Nat Med       Date:  2004-09       Impact factor: 53.440

8.  Combination immunotherapy for high-risk resected and metastatic melanoma patients.

Authors:  Adam I Riker; Gabriela R Rossi; Prerna Masih; L C Alsfeld; Fiona Denham; Lucinda Tennant; W Jay Ramsey; Nicholas N Vahanian; Charles J Link
Journal:  Ochsner J       Date:  2014

9.  Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma.

Authors:  Adil I Daud; Ronald C DeConti; Stephanie Andrews; Patricia Urbas; Adam I Riker; Vernon K Sondak; Pamela N Munster; Daniel M Sullivan; Kenneth E Ugen; Jane L Messina; Richard Heller
Journal:  J Clin Oncol       Date:  2008-11-24       Impact factor: 44.544

10.  Safety and immunologic correlates of Melanoma GVAX, a GM-CSF secreting allogeneic melanoma cell vaccine administered in the adjuvant setting.

Authors:  Evan J Lipson; William H Sharfman; Shuming Chen; Tracee L McMiller; Theresa S Pritchard; January T Salas; Susan Sartorius-Mergenthaler; Irwin Freed; Sowmya Ravi; Hao Wang; Brandon Luber; Janice Davis Sproul; Janis M Taube; Drew M Pardoll; Suzanne L Topalian
Journal:  J Transl Med       Date:  2015-07-05       Impact factor: 5.531
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.